Indivior (INDV)

Profile

Full Name

Indivior PLC

Ticker Symbol

INDV

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

December 29, 2014

Indexes

Not included

Website

http://www.indivior.com

Employees

1030

Key Details

Price

$9.21(+1.60%)

Market cap

Last Dividend

$0.47

TTM Dividend yield

-

Annual revenue

$1.19B(+8.69% YoY)

Annual EPS

$0.02(+102.13% YoY)

PE ratio

-

Next earnings date

Apr 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$9.21
INDV price is $9.21

30-Day Relative Volume

1.07
INDV 30-day relative volume is 1.07

Price Performance

Price Today change

+1.6%
INDV price is up +1.6% today

Price YTD change

-25.95%
INDV price is down -25.95% since January 1st

Price 1-year change

-52.21%
INDV price is down -52.21% year-on-year

Price 3-year change

+113.57%
INDV price is up +113.57% over the past 3 years

Price Range

Price All-time high

$26.50
INDV price is currently -65.26% below its historical high of $26.50

Price 3-year low

$3.00
INDV price is currently +206.83% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.15B
INDV market capitalization is $1.15 billion

Market cap 3-year change

+88.7%
INDV market capitalization is up +88.7% over the past 3 years

Market cap All-time high

$3.42B
INDV market capitalization is currently -66.38% below its historical high of $3.42 billion

Market cap sector rank

78.04%
INDV market capitalization is higher than 78.04% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-8.05%
INDV shares outstanding is down -8.05% year-on-year

Shares Outstanding 3-Year Change

-11.65%
INDV shares outstanding is down -11.65% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.65
INDV beta is 0.65

200-day SMA

$10.75
INDV price is currently -14.37% below its 200-day simple moving average

50-day SMA

$9.59
INDV price is currently -3.97% below its 50-day simple moving average

RSI

44.00
INDV 14-day relative strength index is 44.00

Volume

1.07
INDV 30-day relative volume is 1.07

ATR

$0.45
INDV average true range is $0.45

10-day Historical Volatility

65.22%
INDV 10-day historical volatility is 65.22%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.47
INDV last dividend was $0.47 per share, with an ex-dividend date of June 16, 2016

Next Dividend

-
INDV next dividend has not yet been announced

Dividend per share

Dividend per share

-
INDV annual dividend per share value is unknown

Dividend per share Sector Rank

-
INDV annual dividend per share is unknown

Dividend per share 1-Year Change

-
INDV annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
INDV annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
INDV annual dividend yield value is unknown

Dividend yield Sector Rank

-
INDV annual dividend yield is unknown

Other

Payout ratio

-
INDV annual payout ratio value is unknown

Dividends paid

-
INDV annual dividends paid value is unknown

Free cash flow

-$10.00M
INDV annual free cash flow is -$10.00 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.19B
INDV annual revenue is $1.19 billion

Revenue Analysts estimate

$1.02B
INDV annual revenue is currently +16.15% higher than the consensus analysts' forecast

Revenue 1-year change

+8.69%
INDV annual revenue is up +8.69% year-on-year

Revenue Sector rank

81.63%
INDV annual revenue is higher than 81.63% of companies in Healthcare sector

EPS

EPS

$0.02
INDV annual earnings per share is $0.02

EPS Analysts estimate

$1.13
INDV annual earnings per share is currently -98.23% lower than the consensus analysts' forecast

EPS 1-year change

+102.13%
INDV annual earnings per share is up +102.13% year-on-year

EPS Sector rank

82.56%
INDV annual earnings per share is higher than 82.56% of companies in Healthcare sector

Profit

Gross profit

$930.00M
INDV annual gross profit is $930.00 million

Gross margin

78.28%
INDV annual gross profit margin is 78.28%

Operating profit

-$23.00M
INDV annual operating income is -$23.00 million

Operating margin

-1.94%
INDV annual operating profit margin is -1.94%

Net income

$2.00M
INDV annual net profit is $2.00 million

Net margin

-4.04%
INDV annual net profit margin is -4.04%

Expenses

Total expenses

$1.21B
INDV annual total expenses is $1.21 billion

Operating expenses

$953.00M
INDV annual total operating expenses is $953.00 million

Cost of goods sold

$258.00M
INDV annual cost of goods sold is $258.00 million

Selling, general & administrative expenses

$807.00M
INDV annual SGA is $807.00 million

Depreciation and amortization

$34.00M
INDV annual depreciation & amortization is $34.00 million

Interest expense

$41.00M
INDV annual interest expense is $41.00 million

Income tax

$5.00M
INDV annual income tax is $5.00 million

EBIT & EBITDA

EBIT

$0.00
INDV annual earnings before interest & taxes is $0.00

EBITDA

$34.00M
INDV annual EBITDA is $34.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.32B
INDV annual total assets is $1.32 billion

Non current assets

$637.00M
INDV annual long term assets is $637.00 million

Current assets

$829.00M
INDV annual total current assets is $829.00 million

Cash and cash equivalents

$319.00M
INDV annual cash & cash equivalents is $319.00 million

Accounts receivable

$254.00M
INDV annual accounts receivable is $254.00 million

Inventory

$178.00M
INDV annual inventory is $178.00 million

Liabilities

Total liabilities

$1.67B
INDV annual total liabilities is $1.67 billion

Long term liabilities

$725.00M
INDV annual total long term liabilities is $725.00 million

Current liabilities

$946.00M
INDV annual total current liabilities is $946.00 million

Accounts payable

$63.00M
INDV annual accounts payable is $63.00 million

Debt

Total debt

$375.00M
INDV annual total debt is $375.00 million

Total debt 1-year change

+32.51%
INDV annual total debt is up +32.51% year-on-year

Long term debt

$347.00M
INDV annual long term debt is $347.00 million

Short term debt

$28.00M
INDV annual short term debt is $28.00 million

Equity & Capital

Shareholders equity

-$348.00M
INDV annual stockholders equity is -$348.00 million

Book value

-$205.00M
INDV annual book value is -$205.00 million

Retained earnings

$1.04B
INDV annual retained earnings is $1.04 billion

Working capital

-$117.00M
INDV annual working capital is -$117.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$21.00M
INDV annual cash flow from operations is $21.00 million

Cash from operations 1-year change

+106.67%
INDV annual cash flow from operations is up +106.67% year-on-year

Cash from investing

$69.00M
INDV annual cash flow from investing activities is $69.00 million

Cash from investing 1-year change

+170.41%
INDV annual cash flow from investing activities is up +170.41% year-on-year

Cash from financing

-$87.00M
INDV annual cash flow from financing activities is -$87.00 million

Cash from financing 1-year change

-89.13%
INDV annual cash flow from financing activities is down -89.13% year-on-year

CAPEX

CAPEX

$31.00M
INDV annual capital expenditures is $31.00 million

CAPEX 1-year change

-41.51%
INDV annual capital expenditures is down -41.51% year-on-year

Free Cash Flow

Free cash flow

-$10.00M
INDV annual free cash flow is -$10.00 million

Free cash flow 1-year change

+97.28%
INDV annual free cash flow is up +97.28% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

78.28%
INDV annual gross profit margin is 78.28%

Operating margin

-1.94%
INDV annual operating profit margin is -1.94%

Net margin

-4.04%
INDV annual net profit margin is -4.04%

ROA & ROE

ROA

0.13%
INDV annual return on assets is 0.13%

ROE

-0.57%
INDV annual return on equity is -0.57%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
INDV price to earnings ratio value is unknown

PE ratio Sector rank

-
INDV price to earnings ratio is unknown

PB Ratio

PB ratio

-3.30
INDV price to book ratio is -3.30

PB ratio Sector rank

5.11%
INDV price to book ratio is higher than 5.11% of companies in Healthcare sector

PS Ratio

PS ratio

0.97
INDV price to sales ratio is 0.97

PS ratio Sector rank

27.18%
INDV price to sales ratio is higher than 27.18% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.20B
INDV enterprise value is $1.20 billion

Enterprise value Sector rank

76.96%
INDV enterprise value is higher than 76.96% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

28.01
INDV EV/EBITDA is 28.01

EV/EBITDA Sector rank

94.43%
INDV EV/EBITDA is higher than 94.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.88
INDV annual current ratio is 0.88

Quick ratio

0.69
INDV annual quick ratio is 0.69

Leverage

Debt to equity

-0.96
INDV annual debt to equity ratio is -0.96

Interest coverage ratio

0.00
INDV annual interest coverage ratio is 0.00

Risk & Stability

Piotroski F-Score

7
INDV piotroski f-score is 7

Altman Z-Score

2.31
INDV altman z-score is 2.31

Analyst ratings

Recent major analysts updates

Mar 6, 25 Piper Sandler
Overweight
Oct 25, 24 Piper Sandler
Overweight
Oct 11, 24 Piper Sandler
Overweight
Oct 11, 24 Craig-Hallum
Buy
Sep 13, 24 Piper Sandler
Overweight
Jul 23, 24 Piper Sandler
Overweight
Jul 10, 24 Craig-Hallum
Buy
Apr 3, 24 Craig-Hallum
Buy

Institutional Ownership

Similar stocks

PCRX logo
Pacira BioSciences (PCRX)
MD logo
Pediatrix Medical (MD)
INVA logo
Innoviva (INVA)
PLSE logo
Pulse Biosciences (PLSE)
OCUL logo
Ocular Therapeutix (OCUL)
TNDM logo
Tandem Diabetes Care (TNDM)
ADPT logo
Adaptive Biotechnologies (ADPT)
BGM (BGM)
EVO logo
Evotec SE (EVO)
  • What is the ticker symbol for Indivior?
  • Does Indivior pay dividends?
  • What sector is Indivior in?
  • What industry is Indivior in?
  • What country is Indivior based in?
  • When did Indivior go public?
  • Is Indivior in the S&P 500?
  • Is Indivior in the NASDAQ 100?
  • Is Indivior in the Dow Jones?
  • When was Indivior's last earnings report?
  • When does Indivior report earnings?
  • Should I buy Indivior stock now?

What is the ticker symbol for Indivior?

The ticker symbol for Indivior is NASDAQ:INDV

Does Indivior pay dividends?

No, Indivior does not pay dividends

What sector is Indivior in?

Indivior is in the Healthcare sector

What industry is Indivior in?

Indivior is in the Drug Manufacturers - Specialty & Generic industry

What country is Indivior based in?

Indivior is headquartered in United States

When did Indivior go public?

Indivior's initial public offering (IPO) was on December 29, 2014

Is Indivior in the S&P 500?

No, Indivior is not included in the S&P 500 index

Is Indivior in the NASDAQ 100?

No, Indivior is not included in the NASDAQ 100 index

Is Indivior in the Dow Jones?

No, Indivior is not included in the Dow Jones index

When was Indivior's last earnings report?

Indivior's most recent earnings report was on Feb 20, 2025

When does Indivior report earnings?

The next expected earnings date for Indivior is Apr 25, 2025

Should I buy Indivior stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page